The Technical AnalystExchange: XETRA Sector: Healthcare Industry: Medical Devices
Eckert & Ziegler Strahlen Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.64% €36.98
Europe/Berlin / 2 mai 2024 @ 17:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 770.16 mill |
| EPS: | 1.460 |
| P/E: | 25.33 |
| Earnings Date: | May 14, 2024 |
| SharesOutstanding: | 20.83 mill |
| Avg Daily Volume: | 0.0587 mill |
| RATING 2024-05-02 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.29x |
| Company: PE 25.33 | sector: PE 19.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.65x |
| Company: PE 25.33 | industry: PE 38.87 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€23.24 (-37.16%) €-13.74 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
€ 35.87 - 38.69 ( +/- 3.79%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €36.98 (-0.64% ) |
| Volume | 0.0361 mill |
| Avg. Vol. | 0.0587 mill |
| % of Avg. Vol | 61.50 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For EUZ.DE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
EUZ.DE
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.